| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3297244 | Gastroenterology | 2011 | 10 Pages |
Abstract
Seven of 12 tested commercial kits inaccurately measure plasma concentrations of gastrin; these assays used antibodies with inappropriate specificity that were insufficiently validated. Misdiagnosis of gastrinoma based on lack of specificity of assays for gastrin results in ineffective or inappropriate therapy for patients with ZES.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jens F. Rehfeld, Marie-Hélène Gingras, Linda Bardram, Linda Hilsted, Jens P. Goetze, Pierre Poitras,